Φορτώνει......

Lay media reporting of rosiglitazone risk: extent, messaging and quality of reporting

BACKGROUND: A meta-analysis suggested the use of rosiglitazone was associated with an increased risk for cardiovascular (CV) events. Rosiglitazone remained available for use as more definitive safety trials were ongoing. This issue was reported in the lay media. OBJECTIVE: To review lay media articl...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Rabi, Doreen M, Lewin, Adriane M, Brown, Garielle E, Edwards, Alun L, Johnson, Jeffrey A, Ghali, William A
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BioMed Central 2009
Θέματα:
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2727509/
https://ncbi.nlm.nih.gov/pubmed/19630978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-8-40
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!